Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis.Technology in cancer research & treatment
   Pooled it
2. Advanced Liver Fibrosis Impairs Cardiorespiratory Fitness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.Digestive diseases and sciences · 2025
   Observational
3. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.Food science & nutrition · 2025
   Review
4. Percutaneous ethanol injection is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation.Langenbeck's archives of surgery · 2023
   Article
5. The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1.Science advances · 2021
   Article
6. Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma.Langenbeck's archives of surgery · 2021
   Article
7. Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.Archives of pharmacal research · 2021
   Article
8. The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study.Frontiers in cardiovascular medicine · 2021
   Article
9. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.Lipids in health and disease · 2020
   Article
10. Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor Signaling.Metabolites · 2020
    Article
11. The association of serum total bile acid with non-alcoholic fatty liver disease in Chinese adults: a cross sectional study.Lipids in health and disease · 2020
    Article
12. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis.F1000Research · 2020
    Article
13. Liver Transplantation for Alcohol-Related Liver Disease (ARLD): An Update on Controversies and Considerations.Canadian journal of gastroenterology & hepatology · 2020
    Review
14. Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross-Sectional Population-Based Study on Its Relationship From 1999 to 2016.Hepatology communications · 2019
    Article
15. Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population.Lipids in health and disease · 2019
    Article
16. Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis.Science translational medicine · 2019
    Article
17. Pre-transplant ALBI Grade 3 Is Associated with Increased Mortality After Liver Transplantation.Digestive diseases and sciences · 2019
    Article
18. Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, China.Lipids in health and disease · 2019
    Article
19. Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions.World journal of clinical cases · 2018
    Article
20. Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis.Frontiers in endocrinology · 2018
    Article

Corrections and comments

• Comment on
  Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as